ReviewClinical kidney journal2024
Moderator's view: after SGLT2i and MRA antagonists, where do we go?
Carmine Zoccali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewClinical kidney journal2024
Carmine Zoccali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.